0001161697-23-000610.txt : 20231212
0001161697-23-000610.hdr.sgml : 20231212
20231212170041
ACCESSION NUMBER: 0001161697-23-000610
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231208
FILED AS OF DATE: 20231212
DATE AS OF CHANGE: 20231212
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GRANDE ALICIA
CENTRAL INDEX KEY: 0001402652
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33057
FILM NUMBER: 231481897
MAIL ADDRESS:
STREET 1: 220 MIRACLE MILE
STREET 2: SUITE 234
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0001369568
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
BUSINESS PHONE: (305) 529-2522
MAIL ADDRESS:
STREET 1: 355 ALHAMBRA CIRCLE
STREET 2: SUITE 801
CITY: CORAL GABLES
STATE: FL
ZIP: 33134
FORMER COMPANY:
FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC.
DATE OF NAME CHANGE: 20110215
FORMER COMPANY:
FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc.
DATE OF NAME CHANGE: 20060719
4
1
form4.xml
FORM 4 FOR 12-08-2023
X0508
4
2023-12-08
0
0001369568
CATALYST PHARMACEUTICALS, INC.
CPRX
0001402652
GRANDE ALICIA
355 ALHAMBRA CIRCLE, SUITE 801
CORAL GABLES
FL
33134
0
1
0
0
VP, Treasurer and CFO
0
Common stock, par value $0.001 per share
2023-12-08
4
M
0
40000
1.13
A
90557
D
Common Stock, par value $0.001 per share
2023-12-08
4
S
0
20000
14.25
D
70557
D
Common Stock, par value $0.001 per share
2023-12-08
4
S
0
20000
14.30
D
50557
D
Common Stock, par value $0.001 per share
2023-12-11
4
M
0
60000
1.13
A
110557
D
Common Stock, par value $0.001 per share
2023-12-11
4
S
0
30000
13.74
D
80557
D
Common Stock, par value $0.001 per share
2023-12-11
4
S
0
30000
13.786
D
50557
D
Options to purchase common stock
1.13
2023-12-08
4
M
0
40000
0
D
2024-01-03
Common Stock
40000
1255834
D
Options to purchase common stock
1.13
2023-12-11
4
M
0
60000
0
D
2024-01-03
Common Stock
60000
1195834
D
Ms. Grande sold the shares on the open market, for personal reasons, and to fund the exercise price and tax withholding of the exercise of the stock option, and not as a a result of any disagreement with the Company.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.74 to $13.745 per share.
Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.78 to $13.79 per share.
Options vested in three annual tranches beginning on January 3, 2018.
/s/ Alicia Grande
2023-12-12